Has Charles Upchurch, MD received payments from drug or device companies?

Yes. Drug and device makers reported $342,807 in general payments to Charles Upchurch, MD across 694 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Charles Upchurch, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Charles Upchurch, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Charles Upchurch, MD

Endocrinology, Diabetes & Metabolism · Charlotte, NCNPI 1831246636

Payments from drug & device makers

$342,807in general payments, 2019–2025

Across 694 payments — averaging $493.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Novo Nordisk$202K
Lilly USA, LLC$138K
Boehringer Ingelheim$208
Abbott$201
Amgen$152
Sanofi-aventis U.S. LLC$149
plus $2K from 37 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Novo Nordisk	280	$202,456
Lilly USA, LLC	303	$138,064
Boehringer Ingelheim	11	$208
Abbott	10	$201
Amgen(2 entities)	7	$152
Sanofi-aventis U.S. LLC	7	$149
W. L. Gore & Associates, Inc.	1	$144
Radius Health, Inc.	5	$129
IBSA Pharma Inc.	6	$104
Novartis	4	$82
Amneal Pharmaceuticals LLC	3	$70
BETA Bionics, Inc.	3	$69
AstraZeneca	4	$64
Ascendis Pharma Endocrinology Inc	3	$64
AbbVie	3	$58
Corcept Therapeutics	4	$56
Mannkind Corporation	3	$56
Xeris Pharmaceuticals, Inc.	3	$53
Bayer	3	$50
Tolmar, Inc.	3	$44
Exact Sciences	2	$41
Dexcom, Inc.	2	$39
Cequr Corporation	2	$38
Esperion Therapeutics, Inc.	2	$35
Tandem Diabetes Care, Inc.	2	$35
Edwards Lifesciences	1	$32
Shield Therapeutics Inc	1	$26
Teleflex LLC	1	$23
Clarus Therapeutics Inc.	1	$22
Medtronic	1	$22
Phathom Pharmaceuticals, Inc.	1	$22
Recordati_rare_diseases_inc.	1	$22
GSK	1	$21
Senseonics, Incorporated	1	$20
Amryt Pharma Holdings Ltd	1	$19
Sequel Med Tech, LLC	1	$19
Genentech USA, Inc.	1	$17
Phadia US Inc.	1	$17
Intuity Medical Inc	1	$16
Currax Pharmaceuticals LLC	1	$13
Shire North American Group Inc	1	$12
Companion Medical, Inc.	1	$12
Roche Diabetes Care, Inc.	1	$11

How this compares

$342,807 in reported general payments places this provider in the 85th percentile of 232 endocrinology, diabetes & metabolism providers in North Carolina.

See all endocrinology, diabetes & metabolism providers in North Carolina →

Medicare billing

Part B allowed, 2024

$136,038

Medicare patients

459

Services billed

3,401

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other endocrinology, diabetes & metabolism in Charlotte

Elizabeth HarrisCharlotte$120K
Adam SpitzCharlotte$33K
Raymond StadiemCharlotte$32K
Nisha NathanCharlotte$31K
David BrantleyCharlotte$27K
Kanakasabai NarasimhanCharlotte$25K
Gary RolbandCharlotte$18K
Kathryn LucasMorehead City$37.9M
Mark WarrenGreenville$5M
Mary LawrenceMorehead City$4.9M

See the full list for North Carolina →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →